Compound Detail
CHEMBL1091644
LINSITINIB 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1
Basic Information
| ChEMBL ID | CHEMBL1091644 |
| Name | LINSITINIB |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | PKCDDUHJAFVJJB-VLZXCDOPSA-N |
463
Targets
730
Activities
3
Assay Types
30
PK Parameters
20
Publications
4
Known Names
15
Indications
2
Mechanisms
Molecular Properties
421.5
MW (Da)
4.82
ALogP
6
HBA
2
HBD
89.3
PSA (Ų)
0.44
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Insulin-like growth factor I receptor inhibitor | INHIBITOR | Insulin-like growth factor 1 receptor | ✓ | ✓ |
| Insulin receptor inhibitor | INHIBITOR | Insulin receptor | ✓ | ✓ |
Indications
Adrenal Cortex Neoplasms Breast Neoplasms Carcinoma, Hepatocellular Carcinoma, Non-Small-Cell Lung Head and Neck Neoplasms Neoplasms Prostatic Neoplasms Prostatic Neoplasms, Castration-Resistant Sarcoma, Ewing Small Cell Lung Carcinoma Carcinoma, Squamous Cell Carcinoma, Squamous Cell Colorectal Neoplasms Ovarian Neoplasms Skin Neoplasms
Activity Summary
IC50 709 meas. best 8.7
Kd 19 meas. best 8.0
EC50 2 meas. best 6.98
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Insulin-like growth factor 1 receptor CHEMBL1957 | IC50 | 8.7 | 7.6185 | 2.0 | 20 |
| Mitogen-activated protein kinase 11 CHEMBL3961 | Kd | 8.0 | 8.0 | 10.0 | 1 |
| Insulin receptor CHEMBL1981 | IC50 | 7.8 | 7.245 | 16.0 | 8 |
| Insulin receptor-related protein CHEMBL5483 | IC50 | 7.68 | 6.9733 | 21.0 | 3 |
| SW-620 CHEMBL612262 | IC50 | 7.68 | 6.255 | 21.0 | 2 |
| Mitogen-activated protein kinase; ERK1/ERK2 CHEMBL1907606 | IC50 | 7.55 | 7.55 | 28.0 | 1 |
| A4-Fuk CHEMBL2366356 | IC50 | 7.55 | 7.55 | 28.1 | 1 |
| KS-1 CHEMBL2366228 | IC50 | 7.42 | 7.42 | 38.4 | 1 |
| NIH3T3 CHEMBL614822 | IC50 | 7.22 | 7.165 | 60.0 | 2 |
| Mitogen-activated protein kinase kinase kinase kinase 2 CHEMBL5330 | Kd | 7.17 | 7.17 | 67.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 7.12 | 6.6333 | 75.0 | 3 |
| TE-11 CHEMBL2366166 | IC50 | 7.11 | 7.11 | 78.2 | 1 |
| DU-4475 CHEMBL2366246 | IC50 | 7.07 | 5.825 | 86.0 | 2 |
| EW-1 CHEMBL2366364 | IC50 | 7.07 | 7.07 | 85.8 | 1 |
| HMV-2 cell line CHEMBL614826 | IC50 | 7.05 | 7.05 | 88.5 | 1 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 CHEMBL5393 | EC50 | 6.98 | 6.98 | 104.0 | 1 |
| COLO 205 CHEMBL614561 | IC50 | 6.98 | 6.74 | 104.5 | 2 |
| ES1 CHEMBL2366146 | IC50 | 6.97 | 6.97 | 107.0 | 1 |
| Insulin-like growth factor 1 receptor CHEMBL1957 | Kd | 6.86 | 6.86 | 138.0 | 1 |
| GDM-1 CHEMBL2366157 | IC50 | 6.86 | 6.86 | 136.7 | 1 |
| A673 CHEMBL614517 | IC50 | 6.82 | 5.9 | 153.0 | 2 |
| BXPC-3 CHEMBL614530 | IC50 | 6.82 | 5.55 | 150.0 | 2 |
| ML-2 CHEMBL614356 | IC50 | 6.8 | 6.8 | 159.0 | 1 |
| SAOS-2 CHEMBL614894 | IC50 | 6.78 | 6.78 | 165.3 | 1 |
| MCF7 CHEMBL387 | IC50 | 6.75 | 6.02 | 177.0 | 2 |
| NCI-H1355 CHEMBL2366227 | IC50 | 6.74 | 6.74 | 181.3 | 1 |
| G-401 CHEMBL613509 | IC50 | 6.74 | 6.74 | 182.3 | 1 |
| EW-16 CHEMBL2366358 | IC50 | 6.73 | 6.73 | 187.8 | 1 |
| EW-7 CHEMBL2366112 | IC50 | 6.72 | 6.72 | 188.8 | 1 |
| Serine/threonine-protein kinase LATS1 CHEMBL6167 | Kd | 6.71 | 6.71 | 195.0 | 1 |
| NCI-H727 CHEMBL1075545 | IC50 | 6.7 | 6.7 | 197.9 | 1 |
| Insulin receptor CHEMBL1981 | Kd | 6.7 | 6.7 | 202.0 | 1 |
| Uncharacterized aarF domain-containing protein kinase 5 CHEMBL4105886 | Kd | 6.7 | 6.7 | 202.0 | 1 |
| LCLC-97TM1 CHEMBL1075489 | IC50 | 6.68 | 6.68 | 209.6 | 1 |
| HT-29 CHEMBL384 | IC50 | 6.68 | 6.65 | 210.0 | 2 |
| NCI-H650 CHEMBL1075543 | IC50 | 6.67 | 6.67 | 213.8 | 1 |
| NCI-H2122 CHEMBL1075533 | IC50 | 6.63 | 6.63 | 233.0 | 1 |
| SK-N-DZ CHEMBL1075579 | IC50 | 6.62 | 6.62 | 237.0 | 1 |
| LB771-HNC CHEMBL2366099 | IC50 | 6.59 | 6.59 | 259.1 | 1 |
| LAN-6 CHEMBL2366123 | IC50 | 6.58 | 6.58 | 263.5 | 1 |
| HT-144 CHEMBL2366291 | IC50 | 6.58 | 6.58 | 261.9 | 1 |
| LS-1034 CHEMBL2366072 | IC50 | 6.57 | 6.57 | 271.3 | 1 |
| EW-18 CHEMBL2366097 | IC50 | 6.57 | 6.57 | 270.0 | 1 |
| EW-11 CHEMBL2366223 | IC50 | 6.55 | 6.55 | 284.3 | 1 |
| SNU-C1 CHEMBL2366304 | IC50 | 6.53 | 6.53 | 293.1 | 1 |
| Receptor-type tyrosine-protein kinase FLT3 CHEMBL1974 | Kd | 6.51 | 6.51 | 308.0 | 1 |
| RS4-11 CHEMBL2366159 | IC50 | 6.47 | 6.47 | 337.6 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 1 CHEMBL3587 | Kd | 6.45 | 6.45 | 352.0 | 1 |
| Plasmodium berghei CHEMBL612653 | IC50 | 6.44 | 6.44 | 360.0 | 1 |
| Hepatocyte growth factor receptor CHEMBL3717 | Kd | 6.4 | 6.4 | 395.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 6954.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 23123.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 1066.0 | ng.hr.mL-1 | Canis lupus familiaris |
| AUC | 6770.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 26741.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 87455.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 317487.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 42832.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 424076.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 1328.0 | ng.hr.mL-1 | Canis lupus familiaris |
| CL | 16.98 | uL.min-1.(10^6cells)-1 | Rattus norvegicus |
| CL | 17.38 | mL.min-1.g-1 | Homo sapiens |
| CL | 12.0 | mL.min-1.kg-1 | Mus musculus |
| CL | 4.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 39.0 | mL.min-1.kg-1 | Canis lupus familiaris |
| Cmax | 3420.0 | nM | Mus musculus |
| Cmax | 16040.0 | nM | Mus musculus |
| Cmax | 16800.0 | nM | Mus musculus |
| Cmax | 41990.0 | nM | Mus musculus |
| Cmax | 10010.0 | nM | Rattus norvegicus |
| Cmax | 34640.0 | nM | Rattus norvegicus |
| Cmax | 1200.0 | nM | Canis lupus familiaris |
| F | 84.0 | % | Mus musculus |
| F | 92.0 | % | Rattus norvegicus |
| F | 64.0 | % | Canis lupus familiaris |
| F | 98.0 | % | Mus musculus |
| F | 100.0 | % | Mus musculus |
| F | 84.0 | % | Mus musculus |
| F | 100.0 | % | Mus musculus |
| F | 74.0 | % | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL4689842 | U2OS | 261 |
| - | 10.6019/CHEMBL4689842 | HEK-293T | 261 |
| - | 10.6019/CHEMBL4689842 | Fibroblast | 259 |
| 21425998 | 10.4155/fmc.09.89 | ADMET | 45 |
| - | 10.6019/CHEMBL5674860 | Colon cancer organoid | 12 |
| - | 10.6019/CHEMBL5724558 | Colon cancer organoid | 12 |
| 21425998 | 10.4155/fmc.09.89 | Unchecked | 11 |
| - | 10.6019/CHEMBL5608141 | Colon cancer organoid | 6 |
| 21425998 | 10.4155/fmc.09.89 | NIH3T3 | 6 |
| 21425998 | 10.4155/fmc.09.89 | Insulin-like growth factor 1 receptor | 6 |
| 29191878 | 10.1126/science.aan4368 | Unchecked | 5 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 24900721 | 10.1021/ml400160a | Insulin-like growth factor 1 receptor | 4 |
| 26951753 | 10.1016/j.bmcl.2016.02.075 | Insulin-like growth factor 1 receptor | 3 |
| 26951753 | 10.1016/j.bmcl.2016.02.075 | ADMET | 3 |
| - | 10.6019/CHEMBL3832761 | Plasmodium falciparum | 3 |
| 26951753 | 10.1016/j.bmcl.2016.02.075 | Unchecked | 3 |
| 26951753 | 10.1016/j.bmcl.2016.02.075 | Insulin receptor | 3 |
| 36324498 | 10.1039/d2md00139j | ADMET | 3 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
Data from ChEMBL 36 via Core Engine